☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
autolus therapeutics
Autolus Therapeutics’ Aucatzyl (Obecabtagene Autoleucel) Receives the UA FDA’s Approval to Treat R/R B-Cell Acute Lymphoblastic Le...
November 11, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.